List of Levolet drug patents

Levolet is owned by Genus Lifesciences.

Levolet contains Levothyroxine Sodium.

Levolet has a total of 2 drug patents out of which 0 drug patents have expired.

Levolet was authorised for market use on 06 June, 2003.

Levolet is available in tablet;oral dosage forms.

The generics of Levolet are possible to be released after 23 March, 2038.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231931 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same
Mar, 2038

(15 years from now)

US10406108 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same
Mar, 2038

(15 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 06 June, 2003

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic